Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthCare Global Enterprises (HCG) is India's largest provider of specialty cancer care, operating a comprehensive network of oncology centers across India and Africa. The company provides a full spectrum of oncology services, including molecular diagnostics, genomics, and advanced treatment modalities such as robotic surgery and precision radiation therapy. HCG distinguishes itself through a hub-and-spoke model that brings high-quality cancer care to tier-2 and tier-3 cities. In addition to oncology, the network operates a chain of fertility centers under the Milann brand and maintains a strong focus on clinical research and academic programs. The organization is recognized for integrating cutting-edge technology like CyberKnife and PET-CT into routine clinical practice. HCG also operates a specialized diagnostics division and a dedicated research wing focused on personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HCG Network.